▲ Up
 
06:15 02-08-2015
MAIN АКИpress CA-News
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug maker Shire rejects offer from AbbVie worth $46 billion

Bishkek (AKIpress) - drugs The Irish pharmaceutical company Shire said on Friday that it had rejected a takeover approach from the American drug maker AbbVie that valued the company at 27.2 billion pounds, or about $46.3 billion, the NY Times said. 

AbbVie, which is based in Chicago, revealed on Friday that it had first approached Shire in early May about a possible tie-up, but was rejected three times by Shire’s board of directors – the latest at the end of May. AbbVie was spun off from Abbott Laboratories last year.

Shire called AbbVie’s proposal “unsolicited and highly conditional” and said that it “fundamentally undervalued the company and its prospects.”

“We believe that Shire has a strong independent future,” Susan Kilsby, the Shire chairwoman, said in a statement.

Under British takeover rules, AbbVie has until July 18 to make a firm offer for Shire or walk away for at least six months before coming back with a further unsolicited offer. After three months, it is possible for the sides to reengage if Shire’s board agrees to it.

“There can be no certainty that any firm offer will be made,” AbbVie said in a statement. “Discussions are no longer ongoing.”

The latest cash and share offer was equal to £46.26 a share, AbbVie said.

Shire’s shares rose 13 percent to £42.26 in trading in London on Friday morning.


Twitterfacebookprint
16:29 20.06.2014
LATEST NEWS
17:44 Local election commissions to hang voter lists for check of accuracy until August 2017:38 Extremists of Islamic State expand terrible and subversive activities – Rahmon17:28 Supreme Court cancels ruling unfreezing property belonging to Alexey Eliseyev, Mikhail Nadel17:15 EBRD arranges US$ 300 million syndicated loan for Kazakh Railways17:00 Killer of Cecil the lion should be extradited, Zimbabwe says16:57 Kuwait donates over 17 tons of medical supplies for hospitals in Kyrgyzstan16:56 Kazakhstan, India interested in CASA-1000 Project16:52 Supreme Court confirms theft of criminal case materials on looting during April 201016:43 Kazakh, Malaysian PMs meet in Kuala Lumpur16:33 Rehabilitation of Toktogul HPP to increase its capacity for around 20-40%16:32 Beijing to host 2022 Winter Olympics and Paralympics16:16 Five die, 3 injured in road accident in southern Tajikistan16:09 US dollar exchange rate drops over seasonal factors, expectations of market stakeholders – regulator16:05 China’s anti-corruption watchdog accuses former Inner Mongolia police chief of murder15:59 Several police officers sacked over fight between Kyrgyz, Dungans in Tokmok15:53 President Atambayev signs amendments facilitating export of agricultural products15:47 Vietnam confirms its participation in EXPO 2017 Astana15:45 Uzbekistan creates 100,000 jobs for migrants in six months15:31 Kyrgyz, Kazakh customs authorities talking over facilitation of vegetable exports from Kyrgyzstan15:17 Indian doctors to provide free consultations in Tashkent
Astana
+29° C
Ashgabat
+39° C
Bishkek
+33° C
Dushanbe
+33° C
Tashkent
+37° C
exchange rates
 
66.84
61.11
9.84
1.01
205.18
187.45
30.19
3.11
6.85
6.26
1.01
0.12
2710.18
2512.73
405.44
50.01
3.83
3.50
0.56
0.06

© AKIpress News Agency - 2001-2015. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to www.akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75